iWalk gets $3M, launches BiOM for more amputees (Mass High Tech) Weeks after launching a new version of its bionic ankle for above-the-knee amputees, Bedford-based iWalk Inc. hasreceived $3.1 million in debt financing from a total of nine investors, according to a filing with the Securities and Exchange Commission. The filing does not list the investors in the round, but related persons are listed as President and CEO Tim McCarthy; Vice President of Research and Development Rick Casler; Vice President of Finance Ian Vawter; Founder and CTO Hugh Herr; and directors William Doyle, founder and managing director of WFD Ventures; John Simon, managing director of General Catalyst Partners; William A. Sahlman, professor of Business Administration at Harvard Business School; and Paul Flanagan; managing director of Sigma Partners. The company’s last round of funding came in January 2011, when it received $15 million in equity from Sigma Partners, General Catalyst Partners and New York-based WFD Ventures LLC. IWalk was founded in 2006 by Herr, who lost his legs in a hiking accident. It has benefitted from tens of millions of dollars offered by the U.S. government, according to the company’s ...
Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !

